A PHASE 2b/3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL FOR TREATMENT OF PRIMARY BILIARY CHOLANGITIS (PBC) WITH SETANAXIB: OBJECTIVES AND STUDY DESIGN

被引：0

作者：

Jones, David ^{[1
]}

Carlsson, Stefan ^{[2
]}

Von Reedtz, Sari ^{[2
]}

Levy, Cynthia ^{[3
]}

机构：

[1] Newcastle Univ, Newcastle Upon Tyne Hosp, Dept Hepatol & Liver Transplantat, Newcastle Upon Tyne, Tyne & Wear, England

[2] Calliditas Therapeut AB, Stockholm, Sweden

[3] Univ Miami, Schiff Ctr Liver Dis, Coral Gables, FL 33124 USA

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4700

引用

页码：S1461 / S1462

页数：2

共 50 条

[41] A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
Voss, Tiffini
Lipton, Richard B.
Dodick, David W.
Dupre, Nicole
Ge, Joy Yang
Bachman, Robert
Assaid, Christopher
Aurora, Sheena K.
Michelson, David
CEPHALALGIA, 2016, 36 (09) : 887 - 898
[42] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
Mease, Philip J.
Russell, I. Jon
Arnold, Lesley M.
Florian, Hana
Young, James P.
Martin, Susan A.
Sharma, Uma
JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
[43] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
Miyazaki, Shougo
Hagihara, Akihito
Kanda, Ryo
Mukaino, Yoshito
Nobutomo, Koichi
CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
[44] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
Hengge, UR
Stocks, K
Wiehler, H
Faulkner, S
Esser, S
Lorenz, C
Jentzen, W
Hengge, D
Goos, M
Dudley, RE
Gham, GR
AIDS, 2003, 17 (05) : 699 - 710
[45] Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial
Hordinsky, Maria
Hebert, Adelaide A.
Gooderham, Melinda
Kwon, Ohsang
Murashkin, Nikolay
Fang, Hong
Harada, Kazutoshi
Law, Ernest
Wajsbrot, Dalia
Takiya, Liza
Zwillich, Samuel H.
Wolk, Robert
Tran, Helen
PEDIATRIC DERMATOLOGY, 2023, 40 (06) : 1003 - 1009
[46] NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double Blind Placebo Controlled Trial
Mayo, Marlyn J.
Wigg, Alan J.
Leggett, Barbara A.
Arnold, Hays
Thompson, Alexander J.
Weltman, Martin
Carey, Elizabeth J.
Muir, Andrew J.
Ling, Lei
Rossi, Stephen J.
Depaoli, Alex M.
HEPATOLOGY COMMUNICATIONS, 2018, 2 (09) : 1037 - 1050
[47] Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study
Lang, Jinghe
Yu, Qi
Zhang, Shulan
Li, Huajun
Gude, Kerstin
von Ludwig, Christiane
Ren, Xiaowei
Dong, Liying
JOURNAL OF WOMENS HEALTH, 2018, 27 (02) : 148 - 155
[48] BUSERELIN TREATMENT OF CRYPTORCHIDISM - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
BICA, DTG
HADZISELIMOVIC, F
JOURNAL OF UROLOGY, 1992, 148 (02): : 617 - 621
[49] Pilocarpine spray for the treatment of xerostomia: a randomized, double-blind, placebo-controlled trial
Fragoso Motta, Ana Carolina
Marques, Vanessa Tonetto
Cabral, Fernanda Fortes
dos Santos Polvora, Tabata Larissa
de Macedo, Leandro Dorigan
Alencar Ramos Inocenttini, Lara Maria
Ferreira Duarte, Maira Peres
Oliveira, Fabiola Reis
Rocha, Eduardo Melani
de Freitas, Osvaldo
Tirapelli, Camila
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S319 - S319
[50] A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
Miller, I.
Lynggaard, C. D.
Lophaven, S.
Zachariae, C.
Dufour, D. N.
Jemec, G. B. E.
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 391 - 398

← 1 2 3 4 5 →